These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28983080)

  • 1. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.
    Agnoli C; Grioni S; Pala V; Allione A; Matullo G; Gaetano CD; Tagliabue G; Sieri S; Krogh V
    Sci Rep; 2017 Oct; 7(1):12708. PubMed ID: 28983080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
    Cairat M; Rinaldi S; Navionis AS; Romieu I; Biessy C; Viallon V; Olsen A; Tjønneland A; Fournier A; Severi G; Kvaskoff M; Fortner RT; Kaaks R; Aleksandrova K; Schulze MB; Masala G; Tumino R; Sieri S; Grasso C; Mattiello A; Gram IT; Olsen KS; Agudo A; Etxezarreta PA; Sánchez MJ; Santiuste C; Barricarte A; Monninkhof E; Hiensch AE; Muller D; Merritt MA; Travis RC; Weiderpass E; Gunter MJ; Dossus L
    BMC Med; 2022 Apr; 20(1):118. PubMed ID: 35430795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
    Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
    Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased TNF α, IL-6 and ErbB2 mRNA expression in peripheral blood leukocytes from breast cancer patients.
    Alokail MS; Al-Daghri NM; Mohammed AK; Vanhoutte P; Alenad A
    Med Oncol; 2014 Aug; 31(8):38. PubMed ID: 24961464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
    Assiri AM; Kamel HF; Hassanien MF
    Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.
    Gross AL; Newschaffer CJ; Hoffman-Bolton J; Rifai N; Visvanathan K
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1319-24. PubMed ID: 23651666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
    Dossus L; Franceschi S; Biessy C; Navionis AS; Travis RC; Weiderpass E; Scalbert A; Romieu I; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Bonnet F; Fournier A; Fortner RT; Kaaks R; Aleksandrova K; Trichopoulou A; La Vecchia C; Peppa E; Tumino R; Panico S; Palli D; Agnoli C; Vineis P; Bueno-de-Mesquita HBA; Peeters PH; Skeie G; Zamora-Ros R; Chirlaque MD; Ardanaz E; Sánchez MJ; Ramón Quirós J; Dorronsoro M; Sandström M; Nilsson LM; Schmidt JA; Khaw KT; Tsilidis KK; Aune D; Riboli E; Rinaldi S
    Int J Cancer; 2018 Apr; 142(7):1332-1342. PubMed ID: 29168186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial.
    Macis D; Bellerba F; Aristarco V; Johansson H; Guerrieri-Gonzaga A; Lazzeroni M; Sestak I; Cuzick J; DeCensi A; Bonanni B; Gandini S
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
    Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
    Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin use, adipokine profiles and breast cancer prognosis.
    Wintrob ZA; Hammel JP; Khoury T; Nimako GK; Fu HW; Fayazi ZS; Gaile DP; Forrest A; Ceacareanu AC
    Cytokine; 2017 Jan; 89():45-61. PubMed ID: 27914795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.
    Simone V; D'Avenia M; Argentiero A; Felici C; Rizzo FM; De Pergola G; Silvestris F
    Oncologist; 2016 Apr; 21(4):404-17. PubMed ID: 26865587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
    Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
    Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of adiponectin gene polymorphism and serum level in postmenopausal obese patients with breast cancer.
    Mahmoud EH; Fawzy A; El-Din WM; Shafik NF
    J Cancer Res Ther; 2020; 16(6):1269-1273. PubMed ID: 33342783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk.
    Teras LR; Goodman M; Patel AV; Bouzyk M; Tang W; Diver WR; Feigelson HS
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2553-7. PubMed ID: 19723917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperresistinemia is associated with postmenopausal breast cancer.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.
    Touvier M; Fezeu L; Ahluwalia N; Julia C; Charnaux N; Sutton A; Méjean C; Latino-Martel P; Hercberg S; Galan P; Czernichow S
    Am J Epidemiol; 2013 Jan; 177(1):3-13. PubMed ID: 23171880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.
    Wang T; Rohan TE; Gunter MJ; Xue X; Wactawski-Wende J; Rajpathak SN; Cushman M; Strickler HD; Kaplan RC; Wassertheil-Smoller S; Scherer PE; Ho GY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):971-7. PubMed ID: 21415362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer.
    Peña-Cano MI; Saucedo R; Morales-Avila E; Valencia J; Zavala-Moha JA; López A
    Gynecol Obstet Invest; 2019; 84(4):369-377. PubMed ID: 30650411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.
    Hong T; Liu A; Cai D; Zhang Y; Hua D; Hang X; Wu X
    Cancer Invest; 2013 May; 31(4):279-85. PubMed ID: 23627410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.